RESEARCH-USE BIOSIMILAR ANTIBODY
Garadacimab
Monoclonal antibody · IgG4
Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research.
TARGETF12
YMonoclonal antibody
CATALOGSC-BS-512
CATALOG NUMBERSC-BS-512
MOLECULAR WEIGHTApprox. 146.5 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research.
Garadacimab is a recombinant research-use antibody directed against F12.